Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 22Thoracic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 9Cholangiocarcinoma 7Pancreatic Neoplasms 6Gallbladder Neoplasms 6Ovarian Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Rectal Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Klatskin Tumor 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma 1Resectable Intrahepatic Cholangiocarcinoma 1Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Pelvic Neoplasms 1PRETEXT I Hepatoblastoma 1Mesothelioma, Malignant 1Liposarcoma 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Gastric Adenocarcinoma 1Fibrolamellar hepatocellular carcinoma 1

Interventions

pembrolizumab 49Nivolumab 21Cisplatin 11Cetuximab 11Carboplatin 10Paclitaxel 8Gemcitabine 8Docetaxel 8atezolizumab 7Ipilimumab 7Cyclophosphamide 7spartalizumab 6durvalumab 6Fluorouracil 6Capecitabine 6fludarabine 5avelumab 5Albumin-Bound Paclitaxel 5cemiplimab 4Trastuzumab 4Taxes 4Oxaliplatin 4Leucovorin 4Bevacizumab 4130-nm albumin-bound paclitaxel 4tremelimumab 3tisotumab vedotin 3aldesleukin 3Specimen Handling 3Interleukin-2 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Platinum × Gastrointestinal × Clear all
NCT02495896 2026-04-29

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
61 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡